Lv1
60 积分 2025-03-11 加入
P44 Clinical outcomes, safety and length of stay for patients receiving transarterial chemoembolisation (TACE): a retrospective audit
16天前
已关闭
Pharmacokinetics of Intravenous Uricase-PEG 20, a Drug for Managing Hyperuricemia in Tumor Lysis Syndrome
16天前
已关闭
POS1156 PHASE 1 TRIALS OF NOVEL ORAL ENZYME THERAPY (ALLN-346) FOR HYPERURICEMIA & GOUT: SAFETY, PHARMACODYNAMICS, AND LACK OF SYSTEMIC ABSORPTION OF SINGLE AND MULTIPLE ASCENDING DOSES IN HEALTHY VOLUNTEERS
16天前
已关闭
LRG1 promotes angiogenesis by modulating endothelial TGF-β signalling
4个月前
已完结
Understanding mechanisms of antioxidant action in health and disease
4个月前
已完结
SEDDS facilitate cinnamaldehyde crossing the mucus barrier: The perspective of mucus and Caco-2/HT29 co-culture models
4个月前
已完结
Tissue specificity and species differences in the distribution of urate oxidase in peroxisomes
4个月前
已关闭
Mechanisms and rationale for uricase use in patients with gout
4个月前
已完结
Current Tools and Methods in Molecular Dynamics (MD) Simulations for Drug Design
4个月前
已完结
Fifty years of ‘More is different’
4个月前
已完结
皖公网安备34019202002308
